Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Refractory polymyositis responding to infliximab.

Literature DB >> 15317962

Refractory polymyositis responding to infliximab.

I Uthman, J El-Sayad.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2004 PMID： 15317962 DOI： 10.1093/rheumatology/keh268

Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature.

Authors: Paola Caramaschi; Alessandro Volpe; Antonio Carletto; Lisa M Bambara; Domenico Biasi
Journal: Clin Rheumatol Date: 2007-01-17 Impact factor: 2.980

2. The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

Authors: Khaled M Musallam; Thurayya Arayssi; Ali T Taher; Nadim Kanj; Imad Uthman
Journal: Rheumatol Int Date: 2008-12-04 Impact factor: 2.631

3. Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.

Authors: Yuki Ishikawa; Naoichiro Yukawa; Koichiro Ohmura; Yuji Hosono; Yoshitaka Imura; Daisuke Kawabata; Takaki Nojima; Takao Fujii; Takashi Usui; Tsuneyo Mimori
Journal: Clin Rheumatol Date: 2010-02-09 Impact factor: 2.980

Review 4. Treatment of refractory polymyositis and dermatomyositis.

Authors: Steven R Ytterberg
Journal: Curr Rheumatol Rep Date: 2006-06 Impact factor: 4.592

5. Successful treatment for conventional treatment-resistant dermatomyositis-associated interstitial lung disease with adalimumab.

Authors: Jin-Kyoung Park; Han-Gyul Yoo; Dae-Seon Ahn; Hyun-Soon Jeon; Wan-Hee Yoo
Journal: Rheumatol Int Date: 2011-11-17 Impact factor: 2.631

Refractory polymyositis responding to infliximab.

1. Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature.

2. The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

3. Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature.

Review 4. Treatment of refractory polymyositis and dermatomyositis.

5. Successful treatment for conventional treatment-resistant dermatomyositis-associated interstitial lung disease with adalimumab.

Review 6. Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies.

Review 7. Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Review 8. Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.

Review 9. New onset of dermatomyositis/polymyositis during anti-TNF-α therapies: a systematic literature review.